Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGNT
3926
AGNT Inc
AGNT
$690M
| $223K | ﹤0.01% |
26,280
+12,574
| +92% | +$64.4K |
|
3927
Live Oak Bancshares
LOB
$1.97B
| $223K | ﹤0.01% |
15,440
+6,748
| +78% | +$91.5K |
|
3928
Radiant Logistics
RLGT
$395M
| $223K | ﹤0.01% |
56,844
+43,844
| +337% | +$169K |
|
3929
Sabre
SABR
$886M
| $223K | ﹤0.01% |
27,634
-117,571
| -81% | -$833K |
|
3930
Transmedics
TMDX
$2.78B
| $223K | ﹤0.01% |
12,366
+7,634
| +161% | +$119K |
|
3931
Barrett Business Services
BBSI
$802M
| $222K | ﹤0.01% |
16,780
+7,056
| +73% | +$81.5K |
|
3932
Celsius Holdings
CELH
$6.08B
| $222K | ﹤0.01% |
56,694
+26,493
| +88% | +$62.4K |
|
3933
CALL
Deutsche Bank
DB
$70.7B
| $222K | ﹤0.01% |
23,300
-177,400
| -88% | -$1.37M |
|
3934
Powell Industries
POWL
$7.55B
| $222K | ﹤0.01% |
24,399
+2,463
| +11% | +$20.9K |
|
3935
Protagonist Therapeutics
PTGX
$9.46B
| $222K | ﹤0.01% |
12,591
+6,698
| +114% | +$84K |
|
|
CTXS
3936
CALL
DELISTED
Citrix Systems Inc
CTXS
| $222K | ﹤0.01% |
1,500
-6,700
| -82% | -$964K |
|
|
WUBA
3937
PUT
DELISTED
58.com Inc
WUBA
| $221K | ﹤0.01% |
4,100
-100
| -2% | -$5.16K |
|
3938
Bank First Corp
BFC
$1.72B
| $220K | ﹤0.01% |
3,446
+1,530
| +80% | +$87.8K |
|
3939
SoundThinking
SSTI
$101M
| $220K | ﹤0.01% |
8,736
+120
| +1% | +$3.22K |
|
3940
Fossil Group
FOSL
$344M
| $219K | ﹤0.01% |
47,289
+3,801
| +9% | +$14.6K |
|
|
YARW
3941
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
| $219K | ﹤0.01% |
35
+29
| +483% | +$196K |
|
3942
Peoples Bancorp
PEBO
$1.48B
| $218K | ﹤0.01% |
10,229
+4,235
| +71% | +$92.6K |
|
3943
PUT
Cullen/Frost Bankers
CFR
$10.2B
| $217K | ﹤0.01% |
2,900
-3,900
| -57% | -$272K |
|
3944
First Northwest Bancorp
FNWB
$105M
| $217K | ﹤0.01% |
17,478
+3,458
| +25% | +$40.6K |
|
3945
CGI
GIB
$15.4B
| $217K | ﹤0.01% |
3,453
-97
| -3% | -$6.05K |
|
3946
ICL Group
ICL
$6.8B
| $217K | ﹤0.01% |
71,026
-2,844
| -4% | -$9.53K |
|
|
NPKI
3947
NPK International
NPKI
$1.15B
| $217K | ﹤0.01% |
96,896
+9,626
| +11% | +$16.3K |
|
|
EVFM
3948
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $217K | ﹤0.01% |
5,129
+4,816
| +1,539% | +$325K |
|
3949
CALL
Consolidated Edison
ED
$40.2B
| $216K | ﹤0.01% |
3,000
-27,500
| -90% | -$2.11M |
|
3950
PUT
MPLX
MPLX
$61.3B
| $216K | ﹤0.01% |
12,500
-34,900
| -74% | -$596K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.